Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis
Background In-stent restenosis (ISR) is the primary cause of stroke recurrence after intracranial stenting. Drug-eluting stents (DES) have recently shown great potential for reducing restenosis. This systematic review aimed to evaluate the efficacy and safety of DES compared with bare-metal stents (...
Saved in:
| Main Authors: | Yan Ma, Liqun Jiao, Tao Wang, Bin Yang, Jie Wang, Jichang Luo, Renjie Yang, Wenlong Xu, Haozhi Gong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/12/e085533.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01) -
Efficacy and safety of drug-eluting stents versus bare-metal stents in symptomatic intracranial and vertebral artery stenosis: a meta-analysis
by: Yidan Zhang, et al.
Published: (2024-11-01) -
Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01) -
Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis.
by: Thomas G Poder, et al.
Published: (2017-01-01) -
Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis.
by: Pascal Meier, et al.
Published: (2010-06-01)